首页 | 本学科首页   官方微博 | 高级检索  
     


Phenobarbital and benzodiazepine assisted withdrawal of prolonged pentobarbital treatment for refractory status epilepticus
Affiliation:1. Department of Neurology, Wayne State University/Detroit Medical Center, Detroit, MI 48201, United States;2. Department of Pharmacology, Wayne State University, Detroit Medical Center, Detroit, MI 48201, United States;1. Department of Neurology, HSC T12-020, Stony Brook University, Stony Brook, NY 11794-8121, USA;2. The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care, 3237 South 16th St, Milwaukee, WI 53215, USA;3. Multiple Sclerosis Center of Northeastern New York, 1182 Troy-Schenectady Rd, Ste 105, Latham, NY 12110, USA;4. Hospital Virgen de la Arrixaca, Ctra. Madrid-Cartagena, s/n, Murcia 30120, Spain;5. Cátedra de Neuroinmunología Clínica y Esclerosis Múltiple, UCAM Universidad Católica San Antonio de Murcia, Campus de los Jerónimos, Guadalupe, Murcia 30107, Spain;6. Sanofi, 500 Kendall Street, Cambridge, MA 02142, USA;7. Sanofi, 1 Avenue Pierre Brossolette, Chilly-Mazarin 91385, France;8. Sanofi, 55 Corporate Drive, Bridgewater, NJ 08807, USA;9. St Josef Hospital, Ruhr University Bochum, 5092414 Gudrunstrasse 56, Bochum D-44791, Germany
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号